A Single Arm, Open Label Study to Compare the Pharmacokinetics, Safety, and Efficacy of SPRIX (Intranasal Ketorolac Tromethamine) in 12 to 17 Year Old Patients vs. Adult Patients (18-64 Years) Undergoing Open Surgical Procedures

Trial Profile

A Single Arm, Open Label Study to Compare the Pharmacokinetics, Safety, and Efficacy of SPRIX (Intranasal Ketorolac Tromethamine) in 12 to 17 Year Old Patients vs. Adult Patients (18-64 Years) Undergoing Open Surgical Procedures

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jul 2015

At a glance

  • Drugs Ketorolac (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Luitpold Pharmaceuticals
  • Most Recent Events

    • 21 May 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 13 Jul 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2013-000938-35).
    • 02 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top